Production (Stage)
Eton Pharmaceuticals, Inc.
ETON
$14.30
-$0.21-1.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -162.88% | -195.37% | 120.62% | -274.97% | 64.05% |
| Total Depreciation and Amortization | 185.35% | 27.70% | 6.51% | 11.54% | -28.00% |
| Total Amortization of Deferred Charges | -70.18% | 2,428.21% | -33.90% | 136.00% | 208.70% |
| Total Other Non-Cash Items | 176.88% | 18.01% | -14.05% | 0.12% | 2.69% |
| Change in Net Operating Assets | 99.83% | -283.51% | -58.99% | 213.62% | -281.10% |
| Cash from Operations | 373.20% | -125.91% | 135.22% | 150.75% | -739.02% |
| Capital Expenditure | -- | -- | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 100.00% | -141.03% |
| Cash from Investing | -- | -- | -- | 100.00% | -142.84% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -95.23% | -- | -100.00% | 2,314.29% | -92.31% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -98.83% | 8,820.00% | -78.24% | 42.86% | -28.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 146.65% | -307.44% | 147.06% | 121.95% | -593.99% |